MiniMed Group, Inc. Common Stock
MMED
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.54B
Close$
$44.83
166.7% upside
Current Fair Value
166.7% upsideUndervalued by 166.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.54 Billion |
|---|---|
| Enterprise Value | $5.39 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.29 |
| Beta | -3.71 |
| Outstanding Shares | 281,000,000 |
Return
| Return on Equity | -14.12% |
|---|---|
| Return on Assets | -10.83% |
| Return on Invested Capital | -0.28% |
Valuation & Multiples
| P/E Ratio | -17.92 |
|---|---|
| PEG | 17.92 |
| Price to Sales | 1.53 |
| Price to Book Ratio | 1.4 |
| Enterprise Value to Revenue | 1.69 |
| Enterprise Value to EBIT | -489.76 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$828.52 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 4.9956▲ 499.56% |
|---|---|
| Total Calls | 45,400▲ Infinity% |
| Total Puts | 226,800▲ 219.44% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 13.98%▲ 1.87% |
|---|---|
| Total Invested | $560.52M▲ 15.72% |
| Investors Holding | 105▲ 45.00% |
ESG Score
No data
About MiniMed Group, Inc. Common Stock
CEO: Que Thanh Dallara MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion s...